Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: rationale and design of the EMPA-PCI trial
Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: rationale and design of the EMPA-PCI trial
Guering Eid Lidt, Verena Rafael, Rita Gerardo, M D Rodriguez Guzman Gabriela et al.
Journal
European Heart Journal Open
Topics
Diabetes Treatment and Management
article
Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: rationale and design of the EMPA-PCI trial
Guering Eid Lidt, Verena Rafael, Rita Gerardo, M D Rodriguez Guzman Gabriela, A G D Araiza-Garaygordobil Diego, Ana Mosalina Manuel, Fabio Solis‐Jiménez, José Agustín, Arias Mendoza Maria Alexandra, M. Antonio, Alanna Martin, M. Steve, Alejandro Villalobos-Ordaz, Fernadno Arellano Juvera, Federico Arredondo-Aragon
article en
Abstract
No abstract available for this paper.
Publication Tag
European Heart Journal OpenVol. 5(6)
Institutions
Universidad Autónoma de la Ciudad de México (MX), American Society of Echocardiography (US), Hospital General de México (MX), Instituto Nacional de Cardiología (MX), Benemérita Universidad Autónoma de Puebla (MX), Universidad Autónoma del Estado de Morelos (MX), Universidad Nacional Autónoma de México (MX)